Celsion Corp. Daily Stock Analysis

Daily Stock Analysis, CLSN, Celsion Corp, priceseries

Celsion Corp. Daily Stock Analysis
Stock Information
Open
4.68
Close
4.67
High
4.79
Low
4.44
Previous Close
4.60
Daily Price Gain
0.07
YTD High
9.30
YTD High Date
Jan 4, 2022
YTD Low
4.32
YTD Low Date
Mar 1, 2022
YTD Price Change
-4.35
YTD Gain
-48.20%
52 Week High
35.40
52 Week High Date
Mar 15, 2021
52 Week Low
4.32
52 Week Low Date
Mar 1, 2022
52 Week Price Change
-21.13
52 Week Gain
-81.90%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Sep 14. 2017
21.00
Sep 29. 2017
22.27
11 Trading Days
6.05%
Link
LONG
Oct 6. 2017
50.25
Oct 13. 2017
62.28
5 Trading Days
23.94%
Link
LONG
Nov 20. 2017
32.10
Nov 30. 2017
41.26
7 Trading Days
28.52%
Link
LONG
Mar 2. 2018
33.75
Mar 15. 2018
37.32
9 Trading Days
10.57%
Link
LONG
Jun 14. 2018
39.60
Jun 27. 2018
43.86
9 Trading Days
10.75%
Link
LONG
Jan 14. 2019
28.95
Jan 23. 2019
31.37
6 Trading Days
8.37%
Link
LONG
Apr 7. 2020
14.25
May 1. 2020
18.49
17 Trading Days
29.75%
Link
LONG
May 15. 2020
20.10
Jun 25. 2020
58.66
28 Trading Days
191.82%
Link
LONG
Nov 25. 2020
7.95
Dec 2. 2020
8.48
4 Trading Days
6.72%
Link
LONG
Dec 8. 2020
9.38
Dec 14. 2020
10.02
4 Trading Days
6.83%
Link
LONG
Dec 21. 2020
11.18
Dec 22. 2020
11.89
1 Trading Days
6.38%
Link
LONG
Jan 4. 2021
12.05
Jan 6. 2021
12.70
2 Trading Days
5.41%
Link
LONG
Jan 20. 2021
19.12
Jan 28. 2021
21.02
6 Trading Days
9.90%
Link
LONG
Feb 3. 2021
22.05
Feb 18. 2021
28.39
10 Trading Days
28.75%
Link
LONG
Jun 8. 2021
18.75
Jun 15. 2021
19.84
5 Trading Days
5.80%
Link
Company Information
Stock Symbol
CLSN
Exchange
NasdaqCM
Company URL
http://www.celsion.com
Company Phone
(609) 896-9100
CEO
Michael H. Tardugno
Headquarters
New Jersey
Business Address
997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NJ 08648
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0000749647
About

Celsion Corp. is an oncology drug development company focused on developing a portfolio of innovative cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA- based therapies. Its products include Celsion, ThermoDox, EGEN, TheraPlas and TheraSilence. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Description

Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. The company's lead product includes ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trials for primary liver cancer; and under Phase II clinical trials for recurrent chest wall breast cancer. It has a development, product supply, and commercialization agreement with Yakult Honsha Co. Ltd. for ThermoDox; and a commercial supply agreement with Zhejiang Hisun Pharmaceutical Co. Ltd. for the production of ThermoDox in mainland China, Hong Kong, and Macau. The company also has a collaboration with the Children's Research Institute to conduct a clinical study of ThermoDox, a heat activated liposomal encapsulation of doxorubicin in combination with magnetic resonance-guided high intensity focused ultrasound to treat relapsed or refractory solid tumors in children and young adults. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading